Found 5 matching trials
Safety, Tolerability and Pharmacokinetics of Injectable PEG-Irinotecan (JK-1201I) in Patients with Malignant Solid Tumor
PHASE1The purpose of this clinical trial is to evaluate the safety and tolerabili...
Location
The fifth medical center of PLA general hospital
Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLC
PHASE1The purpose of this clinical trial is to evaluate the safety, tolerability ...
Location
Beijing Cancer Hospital
JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer
PHASE3This study was designed to compare the efficacy and safety of JK-1201I with...
Location
Multiple Locations
JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
PHASE2This study was designed to evaluate the safety, tolerability, efficacy and ...
Location
Beijing Tiantan Hospital
JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases
PHASE2This study was designed to evaluate the safety, efficacy and pharmacokineti...
Location
Multiple Locations